Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor TPM1 via down regulation of its target gene, 13/April/2014, 8.37 am